Role of pulmonary collectins and antimicrobial peptides in patients with pulmonary nontuberculous mycobacteria disease

Role of pulmonary collectins and antimicrobial peptides in patients with pulmonary nontuberculous mycobacteria disease - Collectins and antimicrobial peptides in patients with pulmonary nontuberculous mycobacteria disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027652

Enrollment

Registered

2017-06-09

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nontuberculous mycobacterial disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who match the diagnostic criteria of ATS/IDSA guidelines 2007.

Exclusion criteria

Exclusion criteria: Patients with HIV infection or disseminated MAC infection, without CRT scan data are excluded. Patients whose observational time is less than 12 months.

Design outcomes

Primary

Measure	Time frame
Pulmonary collectins and antimicrobial peptides levels in BALF and blood, composition of microbiome, and disease severity at diagnosis, at a year and two years after diagnosis.	—

Countries

Japan

Contacts

Public ContactKohei Fujita

National Hospital Organization Kyoto Medical Center Respiratory Medicine

kfujita-oka@umin.ac.jp0756419161

Outcome results